Compliance and the world of clinical trials

 

In the world of big data, AI, and analytics— human interaction with technology and the ethics that surround it have become more critical than ever.

The ever-evolving landscape of healthcare and research is no exception to this. With technology advancing at a rate never seen before in our lifetime, we’re now witnessing an increased demand for ethical governance where data, compliance, and human-centred trials collide. 

Spiral Software, at the forefront of clinical trial design, recognises the critical importance of addressing these ethical considerations and how they impact not only the work that we do but also its effect upon our clients and their patients.

Read more about compliance and the way we integrate it into the work we do via our blog.

Perspective Changed, Problem Solved - Meet Cain Harland

Say hello to Cain Harland – Spiral's Development Lead and a bit of an unsung hero. Cain's story isn't your typical tech journey. It starts in the scenic Hawkes Bay and winds its way through a mix of personal training, a flair for web design, and finally, a deep dive into software development.

At Spiral, he's the brains behind the Spinnaker software, quietly revolutionising how we approach clinical trials. Cain's days are a blend of coding, problem-solving, and big-picture thinking, all done with the humble goal of making a real difference in medical research.

From his early days in Wellington to working remotely from the most unexpected places, join us as we explore the life of a man who's as down-to-earth as he is innovative. Read about Cain on our blog

Better Health Outcomes Together - The PANORAMIC Case Study with Lead Statistician Ly-Mee Yu

‘One of the purposes behind the trial is discovering which antivirals are effective in keeping people away from the hospitals as much as they can and alleviating the burden on the healthcare system.'

The PANORAMIC trial is an adaptive platform trial aimed at finding early treatments for COVID-19 by evaluating new antiviral treatments in the community, reducing hospital admissions and easing the burden on the healthcare system.

The trial has recruited over 26,000 people across 65 sites using various recruitment strategies. Spiral’s Spinnaker platform has helped streamline the trial’s software requirements since October 2021. Recent results have shown that Molnupiravir does not reduce hospitalizations or deaths in higher-risk, vaccinated adults with COVID-19.

The trial will continue until a pre-specified probability of superiority or futility is met, and its success is attributed to collaboration within the medical community.

Read more about the trial on our blog.

Meet Anna - Spiral’s new Data Coordinator

We’re thrilled to have Anna on board to continue building upon our world-class product with our renowned friendly kiwi attitude and can-do approach. 

This newly created position includes a lot of project testing and data wrangling Read more about Anna on our blog »